MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
TAIPEI and GENEVA, March 18, 2026 /PRNewswire/ -- Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, has received marketing authorization from the Drug...
Beyond Export to Market Establishment: Hansung ebusiness Presents a Data-Driven "Global One-Stop Distribution" Model for K-Beauty Expansion
SEOUL, South Korea, Feb. 24, 2026 /PRNewswire/ -- Hansung ebusiness announced that it is differentiating itself by introducing a data-driven "Global One-Stop Distribution Solution," designed to support K-beauty indie brands beyond simple export and...